TrademarkDir
EMPOWER PHARMA
LIVE

Serial Number

88262059

Owner

Empower Clinic Services, L.L.C.

Attorney

JOHN A. YATES

First Use Date

Mar 22, 2018

Filing Date

Jan 15, 2019

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

EMPOWER PHARMA Trademark

Serial Number: 88262059 • Registration: 7504902

EMPOWER PHARMA is a trademark filed by Empower Clinic Services, L.L.C. on January 15, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Empower Clinic Services, L.L.C. (22 trademarks)

7601 N. Sam Houston Pkwy. W.
Houston, TX 77064

Entity Type: 16

Empower Pharma, LLC (2 trademarks)

Ste 300
Houston, TX 77041

Entity Type: 16

Trademark Details

Filing Date

January 15, 2019

Registration Date

September 17, 2024

First Use Anywhere

March 22, 2018

First Use in Commerce

March 22, 2018

Published for Opposition

April 2, 2024

Goods & Services

Sterile prescription pharmaceuticals for human use, namely, sterile injectable pharmaceuticals, namely, compounded sterile injectable pharmaceuticals, namely, medications, vitamins, minerals, and supplements, namely, alpha-lipoic acid, ascorbic acid, bacteriostatic water, branched-chain amino acids, vitamin B, mixtures of papaverine and phentolamine, calcium gluconate, mixtures of gamma-aminobutyric acid and magnesium chloride hexahydrate and taurine and theanine, ubiquinone, cyanocobalamin, dexpanthenol, edetate disodium, urofollitropin, growth hormone releasing peptides, human chorionic gonadotropin, ipamoreline acetate, l-arginine HCl, l-carnitine, mixtures of methionine and inositol and choline chloride and cyanocobalamin, mixtures of methionine and inositol and choline chloride and l-carnitine and thiamine HCl and dexpanthenol, mixtures of methionine and inositol and choline chloride, l-lysine HCl, menotropins, methylcobalamin, nandrolone decanoate, phenylephrine HCl, progesterone, pyridoxine HCl, mixtures of papaverine and phentolamine mesylate and prostaglandin and atropine sulfate, sermoreline acetate, sodium bicarbonate, taurine, testosterone cypionate, mixtures of testosterone cypionate and testosterone propionate, testosterone enanthate, testosterone propionate, mixtures of l-arginine HCL and l-citrulline and l-ornithine HCl, and mixtures of papaverine and phentolamine mesylate and prostaglandin E1

Filing History

REGISTERED - SEC. 7 REQUEST ABANDONED
Oct 9, 2025 PRA7
POST REGISTRATION ACTION MAILED - SEC. 7
Mar 28, 2025 PRAM
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 27, 2025 APRE
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 30, 2024 ASGN
TEAS SECTION 7 REQUEST RECEIVED
Oct 29, 2024 ES7R
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 17, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 17, 2024 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Aug 11, 2024 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Apr 29, 2024 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 2, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 2, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 13, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 26, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 26, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 26, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 26, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 26, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 6, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 6, 2024 CRFA
ASSIGNED TO LIE
Jan 5, 2024 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Aug 10, 2023 ERSI
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jun 13, 2023 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 30, 2022 RCSC
ASSIGNED TO EXAMINER
Oct 28, 2022 DOCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 29, 2022 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 29, 2021 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 23, 2021 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 23, 2020 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 23, 2020 RCSC
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 19, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 19, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 19, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 19, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 19, 2020 COAR
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 23, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 23, 2019 GNSL
SUSPENSION LETTER WRITTEN
Oct 23, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 18, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 16, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 16, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 23, 2019 GNRN
NON-FINAL ACTION E-MAILED
Aug 23, 2019 GNRT
NON-FINAL ACTION WRITTEN
Aug 23, 2019 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 2, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 1, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 1, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 3, 2019 GNRN
NON-FINAL ACTION E-MAILED
Apr 3, 2019 GNRT
NON-FINAL ACTION WRITTEN
Apr 3, 2019 CNRT
ASSIGNED TO EXAMINER
Mar 28, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 6, 2019 NWOS

Related Trademarks

More from this Owner

SERVICEMEMBER HEALTH ALLIANCE

SERVICEMEMBER HEALTH ALLIANCE

PROTECT FRONTLINE ALLIANCE

PROTECT FRONTLINE ALLIANCE

EMPOWER ACCESS ALLIANCE

EMPOWER ACCESS ALLIANCE

OUTSOURCING DONE DIFFERENTLY

OUTSOURCING DONE DIFFERENTLY

COMPOUNDING EFFECT

COMPOUNDING EFFECT

PRESCRIPTIONS SIMPLIFIED

PRESCRIPTIONS SIMPLIFIED